Assignee
SEPRACOR INC
US·320 granted patents·75 pending applications·8,073 citations·filing 1985–2010
Top patents by PatentIndex Score
395 records- 0198US7423179B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2006·Granted Sep 9, 2008·12 cites·6 claims
- 0298US6627646B2Norastemizole polymorphsSEPRACOR INC·Filed 2001·Granted Sep 30, 2003·276 cites·13 claims
- 0398US6342496B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 29, 2002·217 cites·19 claims
- 0497US6472563B1Formoterol tartrate process and polymorphSEPRACOR INC·Filed 2001·Granted Oct 29, 2002·78 cites·14 claims
- 0596US7790772B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2009·Granted Sep 7, 2010·15 cites·6 claims
- 0696US7381724B2Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing sameSEPRACOR INC·Filed 2006·Granted Jun 3, 2008·35 cites·5 claims
- 0796US7294637B2Method of treating addiction or dependence using a ligand for a monamine receptor or transporterSEPRACOR INC·Filed 2004·Granted Nov 13, 2007·89 cites·35 claims
- 0896US7189715B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2003·Granted Mar 13, 2007·40 cites·16 claims
- 0996US7125874B2Optically active 5H-pyrrolo[3,4-b] pyrazine derivative, its preparation and pharmaceutical compositions containing sameSEPRACOR INC·Filed 2004·Granted Oct 24, 2006·43 cites·7 claims
- 1096US7087785B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2003·Granted Aug 8, 2006·28 cites·56 claims
- 1196US6762177B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2002·Granted Jul 13, 2004·41 cites·48 claims
- 1296US6458374B1Methods and compositions for treating chronic disorders using optically pure (+)-bupropionSEPRACOR INC·Filed 1999·Granted Oct 1, 2002·118 cites·17 claims
- 1396US6444673B1Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing itSEPRACOR INC·Filed 2000·Granted Sep 3, 2002·71 cites·8 claims
- 1496US6268533B1Formoterol processSEPRACOR INC·Filed 2000·Granted Jul 31, 2001·170 cites·20 claims
- 1596US5077217AMethod for membrane reactor resolution of stereoisomersSEPRACOR INC·Filed 1988·Granted Dec 31, 1991·58 cites·151 claims
- 1696US4800162AMethod for resolution of steroisomers in multiphase and extractive membrane reactorsSEPRACOR INC·Filed 1987·Granted Jan 24, 1989·78 cites·157 claims
- 1795US6645980B1Heterocyclic analgesic compounds and methods of use thereofSEPRACOR INC·Filed 2000·Granted Nov 11, 2003·46 cites·21 claims
- 1895US6369079B1Methods for treating irritable bowel syndrome using optically pure (+) norcisaprideSEPRACOR INC·Filed 2000·Granted Apr 9, 2002·58 cites·10 claims
- 1995US5268097APassivated and stabilized porous mineral oxide supports and method for the preparation and use of sameSEPRACOR INC·Filed 1992·Granted Dec 7, 1993·102 cites·38 claims
- 2094US7615572B2Pyrrole and pyrazole DAAO inhibitorsSEPRACOR INC·Filed 2008·Granted Nov 10, 2009·26 cites·8 claims
- 2194US7465729B2Methods of treatment of menopause and perimenopause using eszopicloneSEPRACOR INC·Filed 2005·Granted Dec 16, 2008·24 cites·4 claims
- 2294US7456173B2Compositions comprising zopiclone derivatives and methods of making and using the sameSEPRACOR INC·Filed 2006·Granted Nov 25, 2008·11 cites·6 claims
- 2394US7145036B2Formoterol tartrate polymorphSEPRACOR INC·Filed 2005·Granted Dec 5, 2006·20 cites·3 claims
- 2494US7105699B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamideSEPRACOR INC·Filed 2005·Granted Sep 12, 2006·18 cites·10 claims
- 2594US6864257B2Optically active 5H-pyrrolo[3,4-b]pyrazine derivative, its preparation and pharmaceutical compositions containing itSEPRACOR INC·Filed 2002·Granted Mar 8, 2005·45 cites·7 claims
- 2694US6476078B2Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunctionSEPRACOR INC·Filed 2001·Granted Nov 5, 2002·43 cites·12 claims
- 2794US6369113B2Method for treating depression using optically pure (−)-bupropionSEPRACOR INC·Filed 2001·Granted Apr 9, 2002·43 cites·11 claims
- 2894US6337328B1Bupropion metabolites and methods of useSEPRACOR INC·Filed 2000·Granted Jan 8, 2002·59 cites·94 claims
- 2994US6291490B1Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipineSEPRACOR INC·Filed 2000·Granted Sep 18, 2001·47 cites·9 claims
- 3094US6057344AMethods for treating hypertension, and angina using optically pure (-) amlodipineSEPRACOR INC·Filed 1994·Granted May 2, 2000·76 cites·16 claims
- 3194US5057427AMethod for resolution of stereoisomersSEPRACOR INC·Filed 1988·Granted Oct 15, 1991·64 cites·70 claims
- 3293US7589237B2Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamineSEPRACOR INC·Filed 2008·Granted Sep 15, 2009·14 cites·8 claims
- 3393US7579370B2Fused heterocyclesSEPRACOR INC·Filed 2007·Granted Aug 25, 2009·25 cites·15 claims
- 3493US6720453B2Formoterol tartrate polymorphSEPRACOR INC·Filed 2002·Granted Apr 13, 2004·34 cites·15 claims
- 3593US6489341B1Methods for the treatment of neuroleptic and related disorders using sertindole derivativesSEPRACOR INC·Filed 2000·Granted Dec 3, 2002·55 cites·37 claims
- 3693US6277887B1Methods for treating Parkinson's disease using optically pure (−)-bupropionSEPRACOR INC·Filed 2000·Granted Aug 21, 2001·37 cites·11 claims
- 3793US6204285B1Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolateSEPRACOR INC·Filed 1997·Granted Mar 20, 2001·158 cites·42 claims
- 3892US7776858B2Methods of treatment of chronic pain using eszopicloneSEPRACOR INC·Filed 2005·Granted Aug 17, 2010·20 cites·4 claims
- 3992US7342132B2Formoterol tartrate process and polymorphSEPRACOR INC·Filed 2006·Granted Mar 11, 2008·13 cites·2 claims
- 4092US7253156B2Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonistsSEPRACOR INC·Filed 2006·Granted Aug 7, 2007·17 cites·25 claims
- 4192US7132551B2Ligands for monoamine receptors and transporters, and methods of use thereofSEPRACOR INC·Filed 2003·Granted Nov 7, 2006·45 cites·17 claims
- 4292US6649183B2Methods for treating apnea and apnea disorders using optically pure R(+) ondansetronSEPRACOR INC·Filed 2001·Granted Nov 18, 2003·37 cites·16 claims
- 4392US6040344AFormoterol processSEPRACOR INC·Filed 1998·Granted Mar 21, 2000·103 cites·10 claims
- 4492US5399765AEnantioselective preparation of optically pure albuterolSEPRACOR INC·Filed 1994·Granted Mar 21, 1995·41 cites·14 claims
- 4592US5258517AMethod of preparing optically pure precursors of paroxetineSEPRACOR INC·Filed 1992·Granted Nov 2, 1993·62 cites·14 claims
- 4692US4754089APhase transfer catalysisSEPRACOR INC·Filed 1986·Granted Jun 28, 1988·39 cites·40 claims
- 4791US7166725B2Benzo[d]isoxazol-3-ol DAAO inhibitorsSEPRACOR INC·Filed 2004·Granted Jan 23, 2007·47 cites·3 claims
- 4891US6992077B2Spirocyclic ligands for sigma receptors, and libraries and methods of use thereofSEPRACOR INC·Filed 2004·Granted Jan 31, 2006·43 cites·90 claims
- 4991US6866839B2Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterolSEPRACOR INC·Filed 2003·Granted Mar 15, 2005·29 cites·18 claims
- 5091US6822099B2Method of resolving amlodipine racemateSEPRACOR INC·Filed 2002·Granted Nov 23, 2004·32 cites·14 claims
Showing the top 50 of 395 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →